Astex Pharmaceuticals
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4420 Rosewood Dr, Pleasanton, California...Phone Number
(925) 560-0100Website
www.astx.comRevenue
$50.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
6
1
2
1
1
About Astex Pharmaceuticals
Founded in 1999, Astex Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs in oncology and other areas. They are based in Pleasanton, California.Explore more
Astex Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Astex Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Astex Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Astex Pharmaceuticals launches new products
Astex Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Astex Pharmaceuticals is spiking on competitors!
Check if Astex Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Astex Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Astex Pharmaceuticals recently announced quarterly report
Click to see if Astex Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Astex Pharmaceuticals
Compare insights from companies similar to Astex Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Astex Pharmaceuticals
$50.7M
51-200
Private
-
1999
AN
Amardeep NeburiSenior Director, Clinical Data Management
Company Profile Activity
Activity Insights
Astex Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Astex Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Astex Pharmaceuticals.
Astex Pharmaceuticals Tech Stack
A closer look at the technologies used by Astex Pharmaceuticals
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Astex Pharmaceuticals has more open roles in Emerging Technology / Innovation than it has had at any time in the past 12 months.
Event
Events
Event
Events
Astex Pharmaceuticals News & Media
Astex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium
CAMBRIDGE, United Kingdom, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, a pharmaceutical company based in Cambridge, UK, dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that it will make five key data presentations at the 36th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics, 23rd-25th October 2024, Barcelona, Spain. The Astex presentations will focus on its nOtsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
LONDON & PLEASANTON, Calif.--(BUSINESS WIRE)--Otsuka Pharmaceutical Europe Ltd. (Otsuka) and Astex Pharmaceuticals, Inc. (Astex) today announce that the European Commission (EC) has approved INAQOVI® (oral decitabine and cedazuridine) as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for standard induction chemotherapy. The EC decision applies to the European Economic Area (EEA), which includes the EU member states, Iceland,Astex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases
CAMBRIDGE and CARDIFF, United Kingdom, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system and The Medicines Discovery Institute, Cardiff University (“MDI”) announced today that they have entered into a multi-year, multimillion pound drug discovery research collaboration, aimed to identify new drugs to treat neurodegeTaiho Oncology and Astex Pharmaceuticals Present Overall Survival Data for Oral Decitabine and Cedazuridine (INQOVI®, ASTX727) in Patients With MDS and CMML Harboring TP53 Mutations at 64th ASH Annual Meeting
Patients in Phase 3 ASCERTAIN study with biallelic TP53 mutations achieved median overall survival (mOS) of 13 months; mOS in the overall study population was 32 months Results indicate potential utility of this oral hypomethylating agent in patients with MDS harboring a TP53 mutation,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Astex Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 1999, Astex Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs in oncology and other areas. They are based in Pleasanton, California.... Read More
